Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC raised its holdings in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBEGet Rating) by 5.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,970 shares of the company’s stock after acquiring an additional 350 shares during the quarter. Janney Montgomery Scott LLC owned 0.18% of Invesco Dynamic Biotechnology & Genome ETF worth $411,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of PBE. Atria Wealth Solutions Inc. acquired a new stake in Invesco Dynamic Biotechnology & Genome ETF during the 1st quarter worth about $221,000. First Republic Investment Management Inc. raised its holdings in Invesco Dynamic Biotechnology & Genome ETF by 59.2% during the 1st quarter. First Republic Investment Management Inc. now owns 12,402 shares of the company’s stock worth $769,000 after buying an additional 4,612 shares during the period. Royal Bank of Canada increased its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 8.8% in the 1st quarter. Royal Bank of Canada now owns 73,653 shares of the company’s stock valued at $4,568,000 after purchasing an additional 5,942 shares during the period. Gerber Kawasaki Wealth & Investment Management increased its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 3,416.7% in the 2nd quarter. Gerber Kawasaki Wealth & Investment Management now owns 159,868 shares of the company’s stock valued at $9,230,000 after purchasing an additional 155,322 shares during the period. Finally, UBS Group AG increased its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 238.1% in the 2nd quarter. UBS Group AG now owns 90,896 shares of the company’s stock valued at $5,249,000 after purchasing an additional 64,015 shares during the period.

Invesco Dynamic Biotechnology & Genome ETF Trading Down 0.2 %

Shares of PBE opened at $67.14 on Tuesday. Invesco Dynamic Biotechnology & Genome ETF has a fifty-two week low of $51.39 and a fifty-two week high of $68.11. The business’s 50-day moving average is $65.04 and its 200-day moving average is $62.91.

About Invesco Dynamic Biotechnology & Genome ETF

(Get Rating)

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Featured Stories

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.